Large-scale testing (Phase 3)Study completedNCT00536484What this trial is testingFesoterodine Flexible Dose StudyWho this might be right forOveractive Bladder Pfizer 896
Early research (Phase 1)Ended earlyNCT06163898What this trial is testingEvaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 4
Not applicableStudy completedNCT01653106What this trial is testingRandomized Trial of Cryotherapy Duration Prior to High Dose Melphalan in Myeloma PatientsWho this might be right forRefractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more Ohio State University Comprehensive Cancer Center 148
Testing effectiveness (Phase 2)UnknownNCT01639326What this trial is testingStudy to Evaluate the Efficacy and Safety of FOLFIRI-AD in Patients With Metastatic Colorectal Cancer UGT1A Genotype 1Who this might be right forMetastatic Colorectal Cancer Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 96
Large-scale testing (Phase 3)UnknownNCT01218789What this trial is testingSafety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light PerceptionWho this might be right forNon 24 Hour Sleep Wake Disorder Vanda Pharmaceuticals 140
Early research (Phase 1)Study completedNCT02260544What this trial is testingBioequivalence Study of Doxorubicin Hydrochloride Liposome InjectionWho this might be right forOvarian Epithelial Cancer Recurrent Dr. Reddy's Laboratories Limited 49
Large-scale testing (Phase 3)WithdrawnNCT04287179What this trial is testingSUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 DiabetesWho this might be right forDiabetes Mellitus, Type 2 Novo Nordisk A/S
Large-scale testing (Phase 3)WithdrawnNCT00269971What this trial is testingDetermine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery.Who this might be right forAnemiaBlood TransfusionOrthopedic Surgery Janssen-Ortho Inc., Canada
Large-scale testing (Phase 3)Study completedNCT00654680What this trial is testingEvaluating the Efficacy and Safety of Vardenafil in Patients Erectile Dysfunction Solely Secondary to Spinal Cord InjuryWho this might be right forErectile Dysfunction Bayer 418
Large-scale testing (Phase 3)Study completedNCT01462357What this trial is testingImmunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old FemalesWho this might be right forInfections, Papillomavirus GlaxoSmithKline 1,079
Very early researchNot Yet RecruitingNCT07728981What this trial is testingBiomarkers, Effectiveness, and Safety of Aflibercept 8mg Modified Fixed Dose Regimen in Treatment-Naïve nAMD PatientsWho this might be right forNeovascular Age-Related Macular Degeneration (nAMD) Wet AMD Tianjin Medical University Eye Hospital 49
Large-scale testing (Phase 3)Study completedNCT01681992What this trial is testingImmunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of LifeWho this might be right forMeaslesMumpsRubella+1 more GlaxoSmithKline 4,538
Early research (Phase 1)Study completedNCT03633591What this trial is testingA Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of TolcaponeWho this might be right forHealthy Volunteers Corino Therapeutics, Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT06254690What this trial is testingThe Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase II Clinical StudyWho this might be right forBreast Cancer The First Affiliated Hospital with Nanjing Medical University 102
Early research (Phase 1)Study completedNCT00136513What this trial is testingSB-743921 In Patients With Solid TumorsWho this might be right forSolid Tumor Cancer GlaxoSmithKline 30
Testing effectiveness (Phase 2)Study completedNCT01770743What this trial is testingSafety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose LevelsWho this might be right forAnthrax Emergent BioSolutions 168
Large-scale testing (Phase 3)Study completedNCT01406938What this trial is testingEfficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose RegimensWho this might be right forModerate to Severe Plaque-type Psoriasis Novartis Pharmaceuticals 967
Testing effectiveness (Phase 2)Study completedNCT02643641What this trial is testingEffect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune ResponseWho this might be right forHypersensitivity Biomay AG 130
Testing effectiveness (Phase 2)Ended earlyNCT00095576What this trial is testingInvestigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)Who this might be right forAIDSHIV Infections Merck Sharp & Dohme LLC 3,000
Testing effectiveness (Phase 2)Study completedNCT04182490What this trial is testingLMN-101 in a Campylobacter Human Challenge ModelWho this might be right forCampylobacter Infections Lumen Bioscience, Inc. 42